Chemplast Sanmar DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.75×0.75×0.65×0.70×0.89×
3.35×24.44×−8.56×1.80×0.53×
−3.6%−0.4%0.5%−3.2%6.6%
0.66×0.66×0.69×0.66×0.86×
3.60×3.60×3.14×3.55×3.14×
−21.9%−15.7%−5.5%−9.5%8.3%
−14.6%−14.6%−5.9%−8.9%8.6%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

CHEMPLASTS₹182.01

Chemplast Sanmar Limited

· Chemicals
₹ CrorePeersDDEVPLSTIKROSSARINOCILHSCLNAVINFLUORKIRIINDUSTATACHEMJUBLCPLMcap ₹2,878 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.890.700.650.750.75
Interest Burden (Pretax/EBIT) ×0.531.80-8.5624.443.35
EBIT Margin %6.60-3.200.45-0.36-3.64
Asset Turnover ×0.860.660.690.660.66
Financial Leverage (Assets/Equity) ×3.143.553.143.603.60
ROE (5-step product, year-end total equity) %8.33-9.45-5.51-15.74-21.87
ROE (owners' profit / average owners' equity) %8.55-8.87-5.86-14.64-14.64
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.